EEburyraised$700M·Growth|SStarcloudraised$200M·Growth|FFunraised$72M·Series A|SStandard Intelligenceraised$75M·Series A|NNetomiraised$110M·Series C|PParallel Web Systemsraised$100M·Series B|RRogoraised$160M·Series D|HHightouchraised$150M·Series D|TTrue Anomalyraised$650M·Series D|SSaronicraised$1.75B·Series D|AAvocaraised$125M·Series B|SSiFiveraised$400M·Series G|SSidewinder Therapeuticsraised$137M·Series B|HHermeusraised$350M·Series C|WWHOOPraised$575M·Series G|
Evolvere BioSciencesEB
EB

Evolvere BioSciences

New

Making next-generation antibiotics that outpace bacterial evolution

Visit
SAASYC S24Est. 20241–10 employeesRemote

Evolvere BioSciences is a S24 YC company. Making next-generation antibiotics that outpace bacterial evolution. They are building innovative solutions in the saas space, backed by Y Combinator's world-class accelerator program.

Total Raised$500K
Y Combinator

Founders

More in SAAS

1Password1P

1Password

The most trusted password manager for teams

NotionNT

Notion

The connected workspace where teams get work done

MixpanelMX

Mixpanel

Self-serve product analytics for software teams

← All startupsMore from USAMore SAAS